Most Viewed
1:31Pooled Analysis of RECORD1, 2, and 3
2:34Results of the Landmark RECORD Programme
2:28'Xarelto' (rivaroxaban) - Most Studied Oral Direct Factor Xa Inhibitor
1:11Desirable Characteristics of an Anticoagulant
1:312:342:281:11Now Playing:
0:24Venous Thrombus Formation and Break Away
Related Videos:
Atrial Fibrillation Can Cause Stroke
0:47Orthopaedic Surgery - a Significant Risk for VTE
0:58Venous Thromboembolism is Serious and Common
1:00Thromboprophylaxis Guidelines in Hip or Knee Replacement Surgery
0:47Needlestick Risk
1:11Desirable Characteristics of an Anticoagulant
1:44Potential Health Economics Benefits of 'Xarelto'
0:50Mode of Action of ‘Xarelto’
1:31Pooled Analysis of RECORD1, 2, and 3
2:36Xarelto Countdown
